Harvard Business Review

OCTOBER 13, 2011

Risk management processes don't — but they should. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 11

Banking Pharmaceuticals Microfinance Risk Management 11

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

NOVEMBER 10, 2017

In one pharmaceutical R&D company, we identified three critical populations that needed to change to enable the execution of the organization’s strategy. Learning in Business Functions Happens Through Processes. The shifts in the processes and approach of the audit team completely shifted this footing. Insight center.

Skills 11

Skills Agility Learning-by-Doing Content 11

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

MARCH 14, 2017

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

Innovation 9

Innovation Company Incentives Industry 9

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Carmakers have started using 3D technology to produce parts. And last year saw the first demonstration of a digital printer producing multilayer, standards-based circuit boards.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. The translation involves people and processes.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. without any compliance process or technology in place.". The risks and penalties are real.

Compliance 15

Compliance Media Compliance Officer Policies 15

Chartered Management Institute

FEBRUARY 26, 2024

Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software. In all sectors, tensions exist between competing pressures such as resources, finance, time and workload.

Uncertainty 52

Uncertainty Risk Management Training Compliance 52

Harvard Business Review

SEPTEMBER 21, 2015

Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. She set up sessions to go over different aspects of the planning process — such as analyzing market data and managing compliance — and facilitated discussions between team members and company experts.

Management 8

Management Pharmaceuticals Learning-by-Doing Marketing 8

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

OCTOBER 24, 2013

In 2012, Congress passed legislation to create a new pathway by which potential “breakthrough” drugs could receive expedited approval, financed by new user fees on the pharmaceutical and medical device industries. If Everyone Hates the FDA Approval Process, Let’s Fix It. Negotiation Strategies for Doctors — and Hospitals.

Health Care 8

Health Care Budgeting Pharmaceuticals Review 8

Harvard Business Review

APRIL 5, 2012

If you know market potential by account segment, you can scale and deploy sales resources appropriately against opportunities and can develop segment-appropriate value propositions and sales processes. Sales force deployment. Some approaches include: • Buy existing data. Deduce the data. Build the data.

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

MAY 15, 2013

It also focuses our attention on the forces that shape behavior in organizations, and so highlights an important question: are all those forces (including structure, processes, and incentives) "culture" or is culture simply the behavioral outputs? "In Culture is a process of "sense-making" in organizations.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

FEBRUARY 4, 2013

For example, the rapidly evolving field of biomimicry examines nature's models and processes to help solve human problems. Breakthrough requires an end to systemic inequities by opening up processes, information - and markets. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

FEBRUARY 26, 2013

But when leaders take this conservative growth approach even when there is reasonable certainty of success and available financing, they undersize their sales forces and forfeit opportunity. An "earn-your-way" strategy is sometimes necessary in markets with high uncertainty or when a company is cash-strapped.

Company 8

Company Short-term Long-term Cost 8

Harvard Business Review

APRIL 23, 2012

For anyone involved in the sales process, a case before the U.S. Supreme Court is expected to rule on whether the work done by pharmaceutical salespeople really counts as "selling." pharmaceutical industry could face billions in retroactive overtime. The salesperson is still a vital link in this process. By June, the U.S.

Pharmaceuticals 14

Pharmaceuticals Banking Objective Incentives 14

Harvard Business Review

JANUARY 10, 2013

billion due to derelict mortgage and foreclosure processes. initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement.

Finance 9

Finance Banking Press Release Pharmaceuticals 9

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

NOVEMBER 20, 2015

Corporate procurement processes are opaque, secretive, and can be influenced by political pull as well as pure performance. In the clubby world of pharmaceutical purchasing executives, PACIV’s reputation for transparency spread, setting a higher bar that his competitors begrudgingly were now asked to jump over.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. It also took into account their roles in changing patient behavior.

Productivity 8

Productivity Products Company Engineering 8

Mills Scofield

NOVEMBER 11, 2014

This is taken from The Intercollegiate Finance Journal (IFJ) is an undergraduate student-run journal about how current finance, economics, business and technology issues affect students'' lives. Please consider supporting the IFJ to ensure that our youth''s voices are heard and heeded. ~~~~~~~~~~~~~~~~~~~~~~~~~~~.

Finance 131

Finance Incentives Education Pharmaceuticals 131

Harvard Business Review

JANUARY 26, 2016

and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields. We recently conducted a survey of CI managers and analysts who’ve been through our training program to see how much their findings influenced major company decisions, and why. They had an average of 6.3

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

JUNE 20, 2017

With the confirmation of Robert Lighthizer as United States trade representative, the long-delayed start of the formal process to begin renegotiation of NAFTA with Canada and Mexico can move forward. Congress of its intent to begin the process. Indeed, on May 18 the Trump administration notified the U.S.

Supply Chain 9

Supply Chain Depreciation Uncertainty Marketing 9

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

Supply Chain 9

Supply Chain Productivity Products Company 9

Harvard Business Review

AUGUST 23, 2016

Both Republicans and Democrats say the most effective board committee is audit/finance. ” Directors of both political views rate their boards similarly on processes, dynamics, and effectiveness as a whole, but differ on the question of compensation. banking & financial services, insurance, real estate); Healthcare (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8